Indoco Remedies Ltd - 532612 - Reg. 34 (1) Annual Report
Annual Report 2018-1901-08-2019
Indoco Remedies gets inspection report from USFDA for its Goa plants
Drug firm Indoco Remedies on Friday said it has received establishment inspection report (EIR) from the US health regulator for its sterile facility26-07-2019
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA clearsIndoco''s Goa Plant II & III26-07-2019
Company news: Indoco Remedies
Indoco Remedies has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral dosages plant in Goa, it said i15-07-2019
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco''s Goa Plant I receives Warning Letter from USFDA15-07-2019
INDOCO REMEDIES LTD. - 532612 - Shareholding for the Period Ended June 30, 2019
Indoco Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here09-07-2019
Indoco Remedies Ltd - 532612 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Jayshankar MenonDesignation :- Company Secretary and Compliance Officer08-07-2019
INDOCO REMEDIES LTD. - 532612 - Board Meeting Intimation for Unaudited Financial Results For First Qtr Ended 30.06.2019
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve Unaudited financial results for the First quarter ended 30.06.201901-07-2019